Japan should fundamentally overhaul its cost-effectiveness assessment (CEA) scheme while putting a hold on CEA-based price adjustments, a new ruling…
HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION JPMA Plans Disclosure of Recipients, Amount of Payments for R&D Outlays
October 3, 2014
-
BUSINESS MTPC Charges Ahead with Research Lab Overhaul to Buttress Drug Discovery
October 2, 2014
-
BUSINESS Novartis Pharma Notifies PMDA of Additional 1,299 Unreported Serious ADRs
October 2, 2014
-
BUSINESS Kissei to Spice Up Current Portfolio in Next 3 Years, Launch New Drugs Later
October 1, 2014
-
BUSINESS e-Detailing Powerhouse M3 to Establish New Firm Dedicated to CSO Biz
September 30, 2014
-
BUSINESS Avigan Administered to Ebola-Infected French Woman: Fujifilm
September 29, 2014
-
ORGANIZATION JPMA Weighs Disclosure of Ad Payments to Commercial Medical Publishers
September 26, 2014
-
BUSINESS Takeda to Invest 2.5 Billion Yen in US Firm for New Drug Development
September 26, 2014
-
BUSINESS AZ Managed to Speed Up Pilot R&D Projects under New Structure: President
September 25, 2014
-
TRENDS Facing Unprecedented Patent Cliff for Abilify, Otsuka Holdings Sets Forth Plan to Achieve Recovery in 2018
September 24, 2014
-
BUSINESS Mediceo Sets to Increase Qualified Reps to 2,000, Enter Contract PMS Biz within 3 Years
September 22, 2014
-
REGULATORY MHLW Guidelines to Call for Thorough Internal Communications at Pharmas after Novartis’ Delayed ADR Reporting
September 19, 2014
-
BUSINESS MTPC Generic Arm Seeks to Quickly Broaden Product Lineup, New Alliance a Possibility: Pres.
September 18, 2014
-
BUSINESS Nippon Shinyaku to Gear Up R&D, Commercialization of Nucleic Acid Products
September 17, 2014
-
BUSINESS Pharmacy Chains Hurrying to Reach Price Settlements with Wholesalers ahead of Sept.-End Deadline
September 16, 2014
-
BUSINESS Takara Bio Pushes for Melanoma Drug Development with Eye on Fast Approval
September 12, 2014
-
REGULATORY Chuikyo’s Drug Pricing Panel to Continue Discussions on Penalties and Actions against Novartis
September 11, 2014
-
REGULATORY Jichi Medical University President Seen as Prime Candidate for Japan NIH Head
September 10, 2014
-
ACADEMIA Prof. Komuro to Issue Objection to Chiba University in Wake of Second Retraction Request Related to VART Study
September 9, 2014
-
BUSINESS All Eyes Glued to Japan Realignment after Mylan’s Buyout of Abbott’s Established Product Biz
September 8, 2014
ページ
Global drug makers are forging ahead with therapies targeting lipoprotein(a), or Lp(a), a promising new approach to reducing cardiovascular risks.…
Japanese Prime Minister Sanae Takaichi said on October 14 that the government will consider the necessary measures for the FY2027…
Eli Lilly’s breast cancer drug Imulrio (imlunestrant) is finally joining Japan’s NHI price list on October 14, nearly 300 days…
The Wednesday TableShe had been on virtual calls since eight in the morning. The screen glowed. Her eyes burned. Plugged into Teams across time zones, she was digitally connected yet entirely isolated from the reality of Japan’s pharma market.She needed…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…